Pharmacological activation of constitutive androstane receptor induces female-specific modulation of hepatic metabolism-Reference-Cited by-同舟云学术

Pharmacological activation of constitutive androstane receptor induces female-specific modulation of hepatic metabolism

Published:2024-01 Issue:1 Volume:6 Page:100930
ISSN:2589-5559
Container-title:JHEP Reports
language:en
Short-container-title:JHEP Reports

Author:

Huillet Marine,Lasserre Frédéric,Gratacap Marie-Pierre,Engelmann Beatrice^ORCID,Bruse Justine,Polizzi Arnaud^ORCID,Fougeray Tiffany,Martin Céline Marie Pauline,Rives Clémence,Fougerat Anne,Naylies Claire,Lippi Yannick^ORCID,Garcia Géraldine,Rousseau-Bacquie Elodie^ORCID,Canlet Cécile,Debrauwer Laurent,Rolle-Kampczyk Ulrike^ORCID,von Bergen Martin,Payrastre Bernard^ORCID,Boutet-Robinet Elisa^ORCID,Gamet-Payrastre Laurence,Guillou Hervé,Loiseau Nicolas^ORCID,Ellero-Simatos Sandrine^ORCID

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology,Immunology and Allergy,Internal Medicine

Reference61 articles.

1. The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism;Wei;Nature,2000

2. The roles of xenobiotic receptors: beyond chemical disposition;Mackowiak;Drug Metab Dispos,2018

3. Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands;Moore;J Biol Chem,2000

4. Induction of bilirubin clearance by the constitutive androstane receptor (CAR);Huang;Proc Natl Acad Sci U S A,2003

5. The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the phenobarbital-responsive enhancer module of the CYP2B gene;Honkakoski;Mol Cell Biol,1998

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fumonisin B₁ induces endoplasmic reticulum damage and inflammation by activating the NXR response and disrupting the normal CYP450 system, leading to liver damage in juvenile quail;Journal of Food Science;2024-07-31

2. Exploiting gender-based biomarkers and drug targets: advancing personalized therapeutic strategies in hepatocellular carcinoma;Frontiers in Pharmacology;2024-06-20